technetium tc 99m dimercaptosuccinic acid has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clotagatide, A; Denoyer, D; Dubois, F; Frere, D; Jeune, NL; Perek, N; Sabido, O | 1 |
1 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and Leukemia
Article | Year |
---|---|
In vitro and in vivo evaluation of the influence of type III NaPi co-transporter activity during apoptosis on 99mTc-(V)DMSA uptake in the human leukaemic cell line U937.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Etoposide; Humans; Leukemia; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Sodium-Phosphate Cotransporter Proteins; Symporters; Technetium Tc 99m Dimercaptosuccinic Acid; Tissue Distribution | 2004 |